A R T I C L E S
Nara et al.
(2S)-(N-tert-Butoxycarbonylamino)-3-(5′-benzyloxypyrimid-2′-
yl)-propionic Acid Methyl Ester (20). The organozinc reagent (1.153
mmol) was prepared in the same way as described for pyridyl
analogue. To the solution of organozinc compound were then
added 2-bromo-5-benzyloxypyrimidine (1.534 mmol, 0.408 g)
and PdCl2(PPh3)2 (0.062 mmol, 0.044 g), and the mixture was
stirred at 50 °C overnight. The reaction mixture was diluted with
ethyl acetate and washed with water and brine. The combined
organic extracts were dried over Na2SO4 and concentrated in vacuo.
The crude oil was subjected to flash chromatography (eluent: ethyl
acetate/hexanes) to yield 55% and was characterized by 1H NMR,
13C NMR, and mass spectrometry. 1H NMR (400 MHz, CDCl3): δ
8.38 (s, 2H, arom.), 7.42-7.35 (m, 5H, arom.), 5.84 (d, 1H, J )
8.4 Hz, 1H, -NH), 5.13 (s, 2H, -CH2), 4.80-4.76 (m, 1H, -CH),
3.69 (s, 3H, -OCH3), 3.50 (dd, J ) 15.4, 5.4 Hz, 1H, HCH), 3.37
(dd, J ) 15.4, 4.6 Hz, 1H, HCH), 1.43 (s, 9H, -C(CH3)3) ppm.
13C NMR (100 MHz, CDCl3): δ 172.45, 159.46, 155.51, 151.16,
144.16, 135.31, 128.85, 128.65, 127.59, 79.74, 70.80, 52.30, 52.12,
39.79, 28.32 ppm. HRMS (ES+) calculated (M) 387.1794, observed
387.1791.
subjected to flash chromatography (eluent: ethyl acetate/hexanes)
1
to yield 57% and was characterized by H NMR, 13C NMR, and
mass spectrometry. 1H NMR (400 MHz, CDCl3): δ 7.45-7.34 (m,
5H, arom.), 6.81 (s, 1H, arom.), 5.89 (d, 1H, J ) 7.6 Hz, 1H, -NH),
4.81 (s, 2H, -CH2), 4.64 (m, 1H, -CH), 3.71 (s, 3H, -OCH3),
3.22 (dd, J ) 14.4, 5.6 Hz, 1H, HCH), 3.14 (dd, J ) 14.6, 4.6 Hz,
1H, HCH), 2.47 (s, 3H, -CH3), 2.23 (s, 3H, -CH3), 1.44 (s, 9H,
-C(CH3)3) ppm. 13C NMR (100 MHz, CDCl3): δ 172.55, 155.52,
151.68, 151.24, 150.92, 140.49, 136.92, 128.61, 128.27, 127.91,
124.03, 79.58, 74.55, 53.19, 52.15, 38.43, 28.34, 19.55, 15.95 ppm.
HRMS (ES+) calculated (M) 414.2155, observed 414.2153.
(2S)-(N-tert-Butoxycarbonylamino)-3-(5′-benzyloxy-4′,6′-dimeth-
ylpyrimidin-2′-yl)-propionic Acid Methyl Ester (24). The orga-
nozinc reagent (1.153 mmol) was prepared in the same way as
described for pyri(mi)dyl analogues. To the solution of organozinc
compound were then added 2-bromo-5-benzyloxy-4,6-dimethylpy-
rimidine (1.153 mmol, 0.339 g), P(o-tolyl)3 (0.125 mmol, 0.038
g), and Pd2dba3 (0.062 mmol, 0.057 g), and the mixture was stirred
at 50 °C overnight. The reaction mixture was diluted with ethyl
acetate and washed with water and brine. The combined organic
extracts were dried over Na2SO4 and concentrated in vacuo. The
crude oil was subjected to flash chromatography (eluent: ethyl
acetate/hexanes) to yield 57% and was characterized by 1H NMR,
13C NMR, and mass spectrometry. 1H NMR (400 MHz, CDCl3): δ
7.38-7.34 (m, 5H, arom.), 5.82 (d, 1H, J ) 8.4 Hz, 1H, -NH),
4.81 (s, 2H, -CH2), 4.77-4.74 (m, 1H, -CH), 3.68 (s, 3H,
-OCH3), 3.43 (dd, J ) 15.8, 5.4 Hz, 1H, HCH), 3.28 (dd, J )
15.6, 4.4 Hz, 1H, HCH), 2.38 (s, 6H, 2 × -CH3), 1.42 (s, 9H,
-C(CH3)3) ppm. 13C NMR (100 MHz, CDCl3): δ 172.49, 160.82,
160.19, 155.50, 148.57, 136.14, 128.71, 128.58, 128.09, 79.65,
75.19, 52.21, 52.01, 39.97, 28.34, 19.07 ppm. HRMS (ES+)
calculated (M) 415.2107, observed 415.2121.
General Procedure for Hydrogenolysis of 5-Benzyloxy Deriva-
tives of Pyri(mi)dines. A solution of benzyloxy protected amino
acid (0.545 mmol, 0.211 g) in 10 mL of MeOH was treated with
5% Pd on C (0.04 g), and the resulting black suspension was stirred
at room temperature under H2 atmosphere (1 atm) overnight. The
catalyst was removed by filtration through a pad of Celite, and
filtrate was concentrated under reduced pressure. The residue was
subjected to flash chromatography (eluent: ethyl acetate/hexanes).
1
The purified product was characterized by H NMR, 13C NMR,
and mass spectrometry. Although the conversion was quantitative
in all of the cases, the purification and isolation of the polar
derivatives led to slightly reduced yields.
1
1
Compound 10. Yield: 81%. H NMR (400 MHz, CDCl3): δ
Compound 13. Yield: 75%. H NMR (400 MHz, CDCl3): δ
8.17 (s, 1H), 7.19 (d, J ) 8 Hz, 1H), 7.08 (d, J ) 8 Hz, 1H), 5.75
(d, J ) 8 Hz, 1H), 4.67 (bs, 1H), 3.72 (s, 3H), 3.22 (m, 2H), 1.41
(s, 9H) ppm. 13C NMR (100 MHz, CDCl3): δ 172.73, 155.58,
152.42, 147.67, 136.74, 124.63, 124.46, 80.08, 53.51, 52.50, 38.36,
28.29 ppm. HRMS (ES+) calculated (M) 296.1372, observed
296.1377.
6.84 (s, 1H), 5.95 (d, J ) 8 Hz, 1H), 4.61 (d, J ) 4 Hz, 1H), 3.73
(s, 3H), 3.19 (m, 2H), 2.45 (s, 3H), 2.25 (s, 3H), 1.43 (s, 9H) ppm.
13C NMR (100 MHz, CDCl3): δ 172.53, 155.63, 148.80, 146.30,
143.66, 134.65, 124.27, 79.79, 53.55, 52.31, 37.60, 28.33, 18.39,
15.92 ppm. HRMS (ES+) calculated (M) 324.1685, observed
324.1686.
1
1
Compound 11. Yield: 82%. H NMR (400 MHz, CDCl3): δ
Compound 14. Yield: 88%. H NMR (400 MHz, CDCl3): δ
9.34 (bs, 1H), 8.30 (s, 2H), 5.95 (d, J ) 8.4 Hz, 1H), 4.79-4.81
(m, 1H), 3.71 (s, 3H), 3.44 (dd, J ) 15.4, 5.8 Hz, 1H), 3.36 (dd,
J ) 15.0, 4.2 Hz, 1H), 1.42 (s, 9H) ppm. 13C NMR (100 MHz,
CDCl3): δ 172.93, 157.53, 155.93, 150.26, 144.69, 80.51, 52.67,
52.35, 39.55, 28.31 ppm. HRMS (ES+) calculated (M) 297.1325,
observed 297.1323.
5.95 (d, 1H, J ) 8.0 Hz, 1H), 4.74-4.72 (m, 1H), 3.70 (s, 3H),
3.40 (dd, J ) 15.4, 5.4 Hz, 1H), 3.26 (dd, J ) 15.4, 4.6 Hz, 1H),
2.40 (s, 6H), 1.42 (s, 9H) ppm. 13C NMR (100 MHz, CDCl3): δ
172.77, 156.55, 155.73, 153.32, 146.22, 80.01, 52.38, 52.24, 39.23,
28.31, 18.64 ppm. HRMS (ES+) calculated (M) 325.1638, observed
325.1647.
5-Benzyloxy-2-bromo-4,6-dimethylpyridine (21). Yield: 33%. 1H
NMR (400 MHz, CDCl3): δ 7.43-7.36 (m, 5H, arom.) 7.14 (s,
1H, arom.), 4.81 (s, 2H, -CH2), 2.48 (s, 3H, -CH3), 2.22 (s, 3H,
-CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 153.69, 151.89,
143.55, 136.46, 134.93, 128.70, 128.49, 128.05, 127.66, 74.85,
19.38, 15.95 ppm. HRMS (ES+) calculated (M) 291.0259, observed
291.0249.
4-Bromo-2,6-dimethylphenol (25). To the solution of 2,6-
dimethylphenol (16.37 mmol, 2.00 g) in acetonitrile (20 mL) was
added NBS (17.189 mmol, 3.06 g), and it was refluxed overnight.
After the completion of reaction as indicated by TLC, the reaction
mixture was concentrated under reduced pressure and residue
reconstituted in ethyl acetate. The organic solution was washed with
water and brine. The combined organic extracts were dried over
Na2SO4 and concentrated in vacuo. The crude residue was subjected
to flash chromatography (eluent: ethyl acetate/hexanes) to yield
5-Benzyloxy-2-bromo-4,6-dimethylpyrimidine (22). Yield: 33%.
1H NMR (400 MHz, CDCl3): δ 7.43-7.41 (m, 5H, arom.), 4.88
(s, 2H, -CH2), 2.44 (s, 6H, 2 × -CH3) ppm. 13C NMR (100 MHz,
CDCl3): δ 163.90, 149.87, 145.21, 135.61, 128.89, 128.86, 128.29,
75.60, 19.14 ppm. HRMS (ES+) calculated (M) 292.0211, observed
292.0208.
1
91%. H NMR (400 MHz, CDCl3): δ 7.13 (s, 2H), 4.69 (s, 1H),
2.24 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 151.32, 131.02,
125.27, 112.04, 15.78 ppm. HRMS (ES+) calculated (M) 199.9837,
observed 199.9831.
(2S)-(N-tert-Butoxycarbonylamino)-3-(5′-benzyloxy-4′,6′-dimeth-
ylpyrid-2′-yl)-propionic Acid Methyl Ester (23). The organozinc
reagent (1.153 mmol) was prepared in the same way as described
for pyri(mi)dyl analogues. To the solution of organozinc compound
were then added 2-bromo-5-benzyloxy-4,6-dimethylpyridine (1.534
mmol, 0.450 g), P(o-tolyl)3 (0.125 mmol, 0.038 g), and Pd2dba3
(0.062 mmol, 0.057 g), and the mixture was stirred at 50 °C
overnight. The reaction mixture was diluted with ethyl acetate and
washed with water and brine. The combined organic extracts were
dried over Na2SO4 and concentrated in vacuo. The crude oil was
4-Bromo-2,6-di-tert-butylphenol (26). To the solution of 2,6-di-
tert-butylphenol (9.709 mmol, 2.00 g) in acetonitrile (20 mL) was
added NBS (10.194 mmol, 1.814 g), and it was refluxed overnight.
After the completion of reaction as indicated by TLC, the reaction
mixture was concentrated under reduced pressure and residue
reconstituted in ethyl acetate. The organic solution was washed with
water and brine. The combined organic extracts were dried over
Na2SO4 and concentrated in vacuo. The crude residue was subjected
to flash chromatography (eluent: ethyl acetate/hexanes) to yield
1
85%. H NMR (400 MHz, CDCl3): δ 7.28 (s, 2H), 5.19 (s, 1H),
9
870 J. AM. CHEM. SOC. VOL. 132, NO. 2, 2010